Stock ATNM ACTINIUM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Actinium Pharmaceuticals, Inc.

Equities

ATNM

US00507W2061

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-16 pm EDT 		5-day change 1st Jan Change
9.77 USD +0.41% Intraday chart for Actinium Pharmaceuticals, Inc. +9.78% +92.32%
May. 15 Actinium Announces Oral Presentation Detailing Improved Survival Outcomes in Tp53 Positive Patients At the Eha 2024 Annual Congress and Presentation of Long-Term Efficacy Results in Older Patients Receiving an Iomab-B Led Bone Marrow Transplant in the Phase 3 Sierra Trial CI
May. 14 Stephens Initiates Actinium Pharmaceuticals With Overweight Rating, $25 Price Target MT

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. ATNM Stock
  4. News Actinium Pharmaceuticals, Inc.
  5. Official Publications
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW